Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Clinical trial NCT04680377 · RECRUITING

Trial details

NCT number: NCT04680377
Sponsor: Jun Zhang, MD, PhD
Status: RECRUITING
Study type: OBSERVATIONAL

NSCLC, Stage III Locally Advanced Lung Carcinoma

Start date: 2021-04-12
Primary completion: 2025-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.